World's Best Scientists 2026 revealed!
Guntram Schernthaner

Guntram Schernthaner

D-Index & Metrics

Medicine

D-Index
77
Citations
26248
World Ranking
18315
National Ranking
101

Guntram Schernthaner publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Guntram Schernthaner sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 359 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Guntram Schernthaner D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Guntram Schernthaner sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Guntram Schernthaner is affiliated with the Medical University of Vienna in Austria. Their research primarily focuses on the field of Medicine, with a special concentration on Endocrinology, Diabetes and Metabolism. Over time, they have contributed to a range of topics related to diabetes treatment, pancreatic function, and metabolic disorders.

The scientist's work spans several key topics including:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Hormonal Regulation and Hypertension
  • Diabetes and associated disorders
  • Diet and metabolism studies
  • Metabolism, Diabetes, and Cancer

Frequent co-authors collaborating with Schernthaner are:

  • Peter Rossing
  • Stefan D. Anker
  • Bertram Pitt
  • Luís M. Ruilope
  • Juliana C.N. Chan

Common publication venues for Schernthaner's research include:

  • Wiener klinische Wochenschrift (4 publications)
  • Diabetes Care (3 publications)
  • Cardiovascular Diabetology (2 publications)
  • Diabetes Obesity and Metabolism (2 publications)
  • Kidney International Reports (1 publication)

Selected recent research papers authored or co-authored by Guntram Schernthaner are:

  • Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes, 2020, Cardiovascular Diabetology
  • Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy, 2021, Kidney International Reports
  • Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure, 2022, Metabolism
  • Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study, 2022, Diabetes Care
  • Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes, 2023, Annals of Internal Medicine

Best Publications

  • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

    John A. Dormandy;Bernard Charbonnel;David J A Eckland;Erland Erdmann

  • Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

    John B Buse;Michael Nauck;Thomas Forst;Wayne H.H. Sheu

  • Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea A 52-week randomized trial

    Guntram Schernthaner;Jorge Luiz Gross;Julio Rosenstock;Michael Guarisco

  • Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

    Jürgen Floege;Joseph Kim;Elizabeth Ireland;Charles Chazot

  • A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

    J. Rosenstock;M. Davies;P. D. Home;J. Larsen

  • Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

    H.P. Kopp;C.W. Kopp;A. Festa;K. Krzyzanowska

  • Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease

    Gavin J. Becker;David C. Wheeler;Dick De Zeeuw;Toshiro Fujita

  • Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes

    Alan Sinclair;John E. Morley;Leo Rodriguez-Mañas;Giuseppe Paolisso

  • Hypoglycemia and Cardiovascular Risks

    Brian M. Frier;Guntram Schernthaner;Simon R. Heller

  • Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial

    G. Schernthaner;D. R. Matthews;B. Charbonnel;M. Hanefeld

  • Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7

    Mohammed I. Hawa;Hubert Kolb;Nanette Schloot;Huriya Beyan

  • Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months.

    I Mühlhauser;V Jörgens;M Berger;W Graninger

  • One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

    Markolf Hanefeld;Paolo Brunetti;Guntram H Schernthaner;David R Matthews

  • Immunogenicity and Allergenic Potential of Animal and Human Insulins

    Guntram Schernthaner

  • Decreased vascular prostacyclin in juvenile-onset diabetes.

    K Silberbauer;G Schernthaner;H Sinzinger;H Piza-Katzer

  • Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.

    J.E. Banatvala;G. Schernthaner;E. Schober;L.M. De Silva

  • Increased visfatin concentrations in women with gestational diabetes mellitus.

    Katarzyna Krzyzanowska;Walter Krugluger;Friedrich Mittermayer;Rupa Rahman

  • Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women

    H.-P. Kopp;K. Krzyzanowska;M. Möhlig;J. Spranger

  • Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515

    G Schernthaner;JL Gross;J Rosenstock;M Guarisco

  • For Training Purposes Only Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea

    Guntram Schernthaner;Jorge L. Gross;Julio Rosenstock;Michael Guarisco

Frequent Co-Authors

Heinz Ludwig
Heinz Ludwig University of Vienna
Paolo Pozzilli
Paolo Pozzilli Università Campus Bio-Medico
Hubert Kolb
Hubert Kolb Heinrich Heine University Düsseldorf
Michael Roden
Michael Roden Heinrich Heine University Düsseldorf
Per-Henrik Groop
Per-Henrik Groop University of Helsinki
Hans-Juergen Woerle
Hans-Juergen Woerle Nestlé (Switzerland)
Itamar Raz
Itamar Raz Hebrew University of Jerusalem
André Scheen
André Scheen University of Liège
Vlado Perkovic
Vlado Perkovic George Institute for Global Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of online degrees and careers in healthcare. For those looking to enter the workforce quickly, accelerated lpn program options offer a fast route into practical nursing with flexible online coursework. Graduates can start their medical careers sooner while balancing other commitments.

Nurses seeking to specialize in mental health may consider the fastest psychiatric nurse practitioner program to advance their qualifications and provide specialized care. These accelerated programs can lead to leadership roles in psychiatric healthcare and are ideal for professionals ready to quickly upskill.

Not all healthcare careers involve direct patient care. Those interested in management or administrative roles can benefit from a health care administration online degree. These programs equip students with the skills to oversee healthcare facilities efficiently. For further advancement, an online mha programs affordable option provides an economical way to earn a master’s in healthcare administration, expanding career opportunities even further.

Best Scientists Citing Guntram Schernthaner

Trending Scientists

Recently Published Articles